Detalhe da pesquisa
1.
Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantation.
Ann Rheum Dis
; 82(5): 670-680, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36653124
2.
Myeloablative autologous haematopoietic stem cell transplantation resets the B cell repertoire to a more naïve state in patients with systemic sclerosis.
Ann Rheum Dis
; 82(3): 357-364, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36241361
3.
Improving outcomes in scleroderma: recent progress of cell-based therapies.
Rheumatology (Oxford)
; 62(6): 2060-2069, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36355455
4.
Lymphocyte subset abnormalities in early severe scleroderma favor a Th2 phenotype and are not altered by prior immunosuppressive therapy.
Rheumatology (Oxford)
; 61(10): 4155-4162, 2022 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35108379
5.
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.
N Engl J Med
; 378(1): 35-47, 2018 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29298160
6.
How I treat refractory chronic graft-versus-host disease.
Blood
; 133(11): 1191-1200, 2019 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30674472
7.
Clinical and Neuroimaging Correlates of Post-Transplant Delirium.
Biol Blood Marrow Transplant
; 26(12): 2323-2328, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32961373
8.
Machine learning predicts stem cell transplant response in severe scleroderma.
Ann Rheum Dis
; 79(12): 1608-1615, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32933919
9.
Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study.
Eur Heart J
; 40(3): 295-305, 2019 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30380032
10.
Application of stem cell transplantation in autoimmune diseases.
Curr Opin Hematol
; 26(6): 392-398, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31490316
11.
Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 25(5): 845-854, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30794930
12.
Recombinant Zoster Vaccine Significantly Reduces the Impact on Quality of Life Caused by Herpes Zoster in Adult Autologous Hematopoietic Stem Cell Transplant Recipients: A Randomized Placebo-Controlled Trial (ZOE-HSCT).
Biol Blood Marrow Transplant
; 25(12): 2474-2481, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31394276
13.
Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts.
Ann Rheum Dis
; 78(1): 122-130, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30409830
14.
Myeloablation followed by autologous stem cell transplantation normalises systemic sclerosis molecular signatures.
Ann Rheum Dis
; 78(10): 1371-1378, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31391177
15.
Bone marrow transplantation for adolescents and young adults with sickle cell disease: Results of a prospective multicenter pilot study.
Am J Hematol
; 94(4): 446-454, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30637784
16.
Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial.
JAMA
; 322(2): 123-133, 2019 07 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31287523
17.
Late Gastrointestinal Complications of Allogeneic Hematopoietic Stem Cell Transplantation in Adults.
Biol Blood Marrow Transplant
; 24(4): 734-740, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29246821
18.
Systemic Sclerosis as an Indication for Autologous Hematopoietic Cell Transplantation: Position Statement from the American Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 24(10): 1961-1964, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29953945
19.
Country-Level Macroeconomic Indicators Predict Early Post-Allogeneic Hematopoietic Cell Transplantation Survival in Acute Lymphoblastic Leukemia: A CIBMTR Analysis.
Biol Blood Marrow Transplant
; 24(9): 1928-1935, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29567340
20.
Manufacture of Autologous CD34+ Selected Grafts in the NIAID-Sponsored HALT-MS and SCOT Multicenter Clinical Trials for Autoimmune Diseases.
Biol Blood Marrow Transplant
; 23(9): 1463-1472, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28602891